Active Ingredient(s): Azacitidine
FDA Approved: * September 1, 2020
Pharm Company: * CELGENE CORP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Onureg Overview

Azacitidine, sold under the brand name Vidaza among others, is a chemical analog of cytidine, a nucleoside in DNA and RNA. Azacitidine and its deoxy derivative, decitabine (also known as 5-aza-2′-deoxycytidine), are used in the treatment of myelodysplastic syndrome. Both drugs were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.[5] Contents 1 Uses 1.1 Clinical 1.2 Non-clinical 2 Mechanism of action 2.1 Inhibition of methylation...

Read more Onureg Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Azacitidine

Recent Onureg Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 100mg, 100mg/vial
  • Powder: 100mg/vial
  • Tablet: 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Onureg: (2 results)

Sorted by National Drug Code
  • 59572-730 Onureg 200 mg Oral Tablet, Film Coated by Celgene Corporation
  • 59572-740 Onureg 300 mg Oral Tablet, Film Coated by Celgene Corporation

Other drugs which contain Azacitidine or a similar ingredient: (2 results)